Wednesday, March 3, 2010

There are Risks to CCSVI Treatment

This is the first I have heard of it, but it appears that the treatment that Dr Zamboni has pioneered to treat MS/CCSVI has not been perfected by others. Evidently, doctors at Stanford Medical Center were performing the treatment, which involves stenting the jugular veins in an attempt to increase the blood flow from the brain, ended badly for two patients. At this time, Stanford Medical Center has ceased performing the procedure.

1 comment:

Dee said...

ONE patient! The death they try to scare us about was unrelated to the procedure. She had a previous condition that caused her death. The other guy did have open heart surgery due to a stent coming loose. All surgeries have a risk. But NO ONE has died from the procedure! Many have died from MS drugs and procedures that HAVE been through all the clinic trials and approved...